Ferreira-Silva, M.; Faria-Silva, C.; Carvalheiro, M.C.; Simões, S.; Marinho, H.S.; Marcelino, P.; Campos, M.C.; Metselaar, J.M.; Fernandes, E.; Baptista, P.V.;
et al. Quercetin Liposomal Nanoformulation for Ischemia and Reperfusion Injury Treatment. Pharmaceutics 2022, 14, 104.
https://doi.org/10.3390/pharmaceutics14010104
AMA Style
Ferreira-Silva M, Faria-Silva C, Carvalheiro MC, Simões S, Marinho HS, Marcelino P, Campos MC, Metselaar JM, Fernandes E, Baptista PV,
et al. Quercetin Liposomal Nanoformulation for Ischemia and Reperfusion Injury Treatment. Pharmaceutics. 2022; 14(1):104.
https://doi.org/10.3390/pharmaceutics14010104
Chicago/Turabian Style
Ferreira-Silva, Margarida, Catarina Faria-Silva, Manuela C. Carvalheiro, Sandra Simões, H. Susana Marinho, Paulo Marcelino, Maria Celeste Campos, Josbert M. Metselaar, Eduarda Fernandes, Pedro V. Baptista,
and et al. 2022. "Quercetin Liposomal Nanoformulation for Ischemia and Reperfusion Injury Treatment" Pharmaceutics 14, no. 1: 104.
https://doi.org/10.3390/pharmaceutics14010104
APA Style
Ferreira-Silva, M., Faria-Silva, C., Carvalheiro, M. C., Simões, S., Marinho, H. S., Marcelino, P., Campos, M. C., Metselaar, J. M., Fernandes, E., Baptista, P. V., Fernandes, A. R., & Corvo, M. L.
(2022). Quercetin Liposomal Nanoformulation for Ischemia and Reperfusion Injury Treatment. Pharmaceutics, 14(1), 104.
https://doi.org/10.3390/pharmaceutics14010104